Building a Phase 1 Cancer Research Program: Lessons Learned and Progress Made

REFERENCES

1. 1.↵
   1. Von Hoff DD,
   2. Turner J

   Response rates, duration of response, and dose response effects in phase I studies of antineoplastics. Invest New Drugs. 1991 2; 9 1: 115- 122. pmid:1827432

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Kato S,
   2. Subbiah V,
   3. Kurzrock R

   Counterpoint: successes in the pursuit of precision medicine: biomarkers take credit. J Natl Compr Canc Netw. 2017 7; 15 7: 863- 866. doi: 10.6004/jnccn. 2017.0127. pmid:28687573

   OpenUrlFREE Full Text
3. 3.↵
   1. Kardinal CG,
   2. Bateman M

   The Ochsner Cancer Institute clinical trials program. Ochsner J. 2006 Spring; 6 1: 28- 30. pmid:21765782

   OpenUrlFREE Full Text